Table 2.
Changes of maximal length of epiretinal scar after anti-VEGF treatments at 28 days after OGI.
| Group | Epiretinal scar length | P value∗ |
|---|---|---|
| ( , μm) | ||
| Control | 0 | — |
| OGI | 503 ± 82.44 | — |
| OGI + Ranibizumab | 355 ± 43.66 | 0.244 |
| OGI + Conbercept | 250.33 ± 36.02 | 0.048 |
∗P values were compared with OGI group by one-way ANOVA with Tukey's multiple comparisons test. Data are mean ± SD, n = 3.